
Quick Links
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
NORTHBROOK, Ill., June 9, 2015 /PRNewswire/ -- Astellas today announced that Tarsis Lopez has been appointed to the role of associate director, external and digital communications, as part of the...
Read more about Tarsis Lopez joins Astellas Corporate Affairs
NORTHBROOK, Ill., (June 4, 2015) — The Astellas USA Foundation today announced joining the American Red Cross Disaster Responder Program, which gathers donations in advance of major disasters to...
Read more about Astellas USA Foundation joins the American Red Cross Disaster Responder Program
NORTHBROOK, Ill. and ASPEN, Colo., June 4, 2015 /PRNewswire/ -- The Chris Klug Foundation (CKF) is pleased to announce the winners of the second annual Bounce Back Award, presented by Astellas....
TOKYO and NORTHBROOK, Ill., June 1, 2015 /PRNewswire/ -- Astellas Pharma Inc. (Tokyo: 4503) announced that data from a Phase 2 study evaluating the investigational use of enzalutamide as a single...
Data Presented in Plenary Session at AUA 2015 TOKYO and NEW ORLEANS, May 17, 2015 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) announced today that results from its Phase 3b BESIDE clinical...